Transjugular Liver Biopsy: Safe Even in Patients With Severe Coagulopathies and Multiple Biopsies

摘要

To investigate the safety profile and diagnostic efficacy of transjugular liver biopsy (TJLB), with a focus on patients with severe coagulopathies and with multiple biopsies.Clinical, laboratory, and demographic information was collected on 1,321 TJLBs in 932 patients (mean age 43.5 23.2 years) performed between January 2009 and May 2017 to determine the diagnostic success rate and incidence of both major and minor complications in the 3-day and 30-day period post-biopsies. These outcomes were also analyzed for severely coagulopathic patients and a subgroup of patients who underwent multiple biopsies.